Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

330 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The association of nephrolithiasis with cystic fibrosis.
Gibney EM, Goldfarb DS. Gibney EM, et al. Among authors: goldfarb ds. Am J Kidney Dis. 2003 Jul;42(1):1-11. doi: 10.1016/s0272-6386(03)00403-7. Am J Kidney Dis. 2003. PMID: 12830451 Review.
Use of a probiotic to decrease enteric hyperoxaluria.
Lieske JC, Goldfarb DS, De Simone C, Regnier C. Lieske JC, et al. Among authors: goldfarb ds. Kidney Int. 2005 Sep;68(3):1244-9. doi: 10.1111/j.1523-1755.2005.00520.x. Kidney Int. 2005. PMID: 16105057 Clinical Trial.
Opioid Overuse or NSAID Underuse? A Response to the Pain Guide.
Hiremath S, Goldfarb DS, Juurlink DN. Hiremath S, et al. Among authors: goldfarb ds. Am J Kidney Dis. 2017 Jun;69(6):865. doi: 10.1053/j.ajkd.2017.02.375. Epub 2017 Apr 25. Am J Kidney Dis. 2017. PMID: 28454686 No abstract available.
Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.
Noori N, Honarkar E, Goldfarb DS, Kalantar-Zadeh K, Taheri M, Shakhssalim N, Parvin M, Basiri A. Noori N, et al. Among authors: goldfarb ds. Am J Kidney Dis. 2014 Mar;63(3):456-63. doi: 10.1053/j.ajkd.2013.11.022. Am J Kidney Dis. 2014. PMID: 24560157 Clinical Trial.
Prevention of recurrent nephrolithiasis.
Goldfarb DS, Coe FL. Goldfarb DS, et al. Am Fam Physician. 1999 Nov 15;60(8):2269-76. Am Fam Physician. 1999. PMID: 10593318 Review.
330 results